Citalopram Hydrobromide
Product Images NDC 53002-2360

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Citalopram Hydrobromide (NDC 53002-2360). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rpk Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (B35147fd 7d3d 47bc Beca B3a7c3762ed1 01)

Chemical structure of citalopram hydrobromide, showing its molecular framework including an aromatic ring with fluorine substitution, a cyanide group, and a side chain with a tertiary amine linked to a hydrobromide (HBr) salt.*

FDA Label Image

Logo (B35147fd 7d3d 47bc Beca B3a7c3762ed1 02)

FDA Label Image

Logo (B35147fd 7d3d 47bc Beca B3a7c3762ed1 03)

FDA Label Image

Label Image (Lbl530022360)

This is the packaging label for Citalopram Hydrobromide 40 mg tablets by RPK Pharmaceuticals, Inc. The label indicates a package containing 30 tablets, with directions to take one tablet daily or as directed. It includes prescription information, lot number, expiration date, NDC codes, and space for clinic name, patient name, and prescription details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.